Zdrowie i gospodarka · 16/04/2026
FDA Clears REVIA Tablets for Sale
The FDA has determined that REVIA tablets, 50mg, were not withdrawn from sale due to safety or effectiveness concerns, allowing the agency to continue approving abbreviated new drug applications for the product.